Research ArticleAccepted Article
Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID)
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy and Alexis Ogdie
The Journal of Rheumatology October 2019, jrheum.190219; DOI: https://doi.org/10.3899/jrheum.190219
Jessica A. Walsh
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Marilyn T. Wan
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Christine Willinger
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
M. Elaine Husni
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Jose U. Scher
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Soumya M. Reddy
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Alexis Ogdie
From the Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; New York University School of Medicine, New York, NY, USA. Funding: This work was supported by NIH/NIAMS R01 AR072363. Dr. Walsh has received consulting fees or research grants from Novartis, AbbVie, Amgen, Lilly, and Pfizer Dr. Husni has received consulting fees, speaking fees, and/or honoraria from AbbVie, Janssen, Sanofi Genzyme/Regeneron, UCB, Novartis, and Lilly (less than $10,000 each) and is a coinventor on a patent for a psoriatic arthritis questionnaire (Psoriatic Arthritis Screening Evaluation), for which she receives royalties. Dr. Reddy has received consulting fees, speaking fees, and/or honoraria from Novartis, AbbVie, Amgen, UCB, and Pfizer (less than $10,000 each). Dr. Scher has received consulting fees from Janssen, UCB, BMS (less than $10,000 each), consulting fees from Novartis (more than $10,000) and consulting fees or research grants from Novartis to NYU Langone Health. Dr. Ogdie has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Corrona, Lilly, Novartis, Pfizer, and Takeda (less than $10,000 each). Grants from Novarits and Pfizer to the trustees of University of Pennsylvania. Royalties to husband from Novartis (greater than $10,000). Dr. Wan and Ms. Willinger have no relevant financial disclosures with respect to the work presented. Corresponding Author: Alexis Ogdie, Division of Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; tel: 215-615-4375; fax: 215-662-4500; alexis.ogdie@uphs.upenn.edu
Article Figures & Data
Additional Files
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID)
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy, Alexis Ogdie
The Journal of Rheumatology Oct 2019, jrheum.190219; DOI: 10.3899/jrheum.190219
Accepted manuscript
Measuring outcomes in psoriatic arthritis: comparing Routine Assessment of Patient Index Data (RAPID3) and Psoriatic Arthritis Impact of Disease (PSAID)
Jessica A. Walsh, Marilyn T. Wan, Christine Willinger, M. Elaine Husni, Jose U. Scher, Soumya M. Reddy, Alexis Ogdie
The Journal of Rheumatology Oct 2019, jrheum.190219; DOI: 10.3899/jrheum.190219